Trial of a preferential Phosphodiesterase 4B Inhibitor for idiopathic pulmonary fibrosis.
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis – New England Journal of Medicine (link to abstract – $ for full-text) Commentary on Twitter In a placebo-controlled trial, treatment with the phosphodiesterase 4 inhibitor BI 1015550 prevented a decrease in lung function over a 12-week period in patients with idiopathic pulmonary […]
The post Trial of a preferential Phosphodiesterase 4B Inhibitor for idiopathic pulmonary fibrosis. appeared first on Links Medicus.
RCT: Albuterol–budesonide fixed-dose combination rescue inhaler for asthma.
Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma – New England Journal of Medicine (link to abstract – $ for full-text) Commentary on Twitter The risk of severe asthma exacerbation was significantly lower with as-needed use of a fixed-dose combination of 180 μg of albuterol and 160 μg of budesonide than with albuterol alone. #ATS2022 […]
The post RCT: Albuterol–budesonide fixed-dose combination rescue inhaler for asthma. appeared first on Links Medicus.
RCT: Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure.
Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial – JAMA Related: Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled Trial – JAMA Internal Medicine Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic […]
The post RCT: Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure. appeared first on Links Medicus.
[Preprint] Long Covid: A systematic review and meta-analysis of 120,970 patients.
Long Covid: A Systematic Review and Meta-Analysis of 120,970 Patients – Preprints with The Lancet Commentary on Twitter A systematic #LongCovid review of nearly 200 studies and over 120,000 participants, reinforces the high frequency of symptoms > 6 months, not linked to severity of acute illness, and potential for marked disabilityhttps://t.co/9NYQT1P79G pic.twitter.com/WFzBqghbGI — Eric […]
The post [Preprint] Long Covid: A systematic review and meta-analysis of 120,970 patients. appeared first on Links Medicus.
Cohort Study: Health outcomes in people 2 years after surviving hospitalization with COVID-19.
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study – The Lancet Respiratory Medicine News Release: Two years after infection, half of people hospitalized with COVID-19 have at least one symptom, follow-up study suggests – Lancet
The post Cohort Study: Health outcomes in people 2 years after surviving hospitalization with COVID-19. appeared first on Links Medicus.
IDSA updates guidelines on the treatment and management of patients with COVID-19.
IDSA Guidelines on the Treatment and Management of Patients with COVID-19 – Infectious Diseases Society of America
The post IDSA updates guidelines on the treatment and management of patients with COVID-19. appeared first on Links Medicus.
Review of thoracic imaging manifestations of COVID-19 and other pathologic Coronaviruses.
Review of Thoracic Imaging Manifestations of COVID-19 and Other Pathologic Coronaviruses – Radiology Clinics of North America
The post Review of thoracic imaging manifestations of COVID-19 and other pathologic Coronaviruses. appeared first on Links Medicus.
New versions of Omicron are masters of immune evasion.
New versions of Omicron are masters of immune evasion – Science Commentary on Twitter "Based on its immunological profile, it [Omicron & its subvariants] should be called SARS-3"https://t.co/zxV3T2SKIB@gretchenvogel @NewsfromScience w/ @K_G_Andersen @Tuliodna @linfa_wang pic.twitter.com/ToKDqNGH74 — Eric Topol (@EricTopol) May 12, 2022
The post New versions of Omicron are masters of immune evasion. appeared first on Links Medicus.
Interstitial lung disease in infancy and early childhood: a clinicopathological primer.
Interstitial lung disease in infancy and early childhood: a clinicopathological primer – European Respiratory Review
The post Interstitial lung disease in infancy and early childhood: a clinicopathological primer. appeared first on Links Medicus.
Review: Mucus clearance strategies in mechanically ventilated patients.
Mucus Clearance Strategies in Mechanically Ventilated Patients – Frontiers in Physiology
The post Review: Mucus clearance strategies in mechanically ventilated patients. appeared first on Links Medicus.